Foundation for Innovative New Diagnostics - Product Pipeline Analysis, 2017 Update

Date: April 20, 2017
Pages: 29
Price:
US$ 750.00 US$ 675.00
Offer valid until September 1, 2017!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F8FB738B696EN
Leaflet:

Download PDF Leaflet

Foundation for Innovative New Diagnostics - Product Pipeline Analysis, 2017 Update
Summary

Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Foundation for Innovative New Diagnostics
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Foundation for Innovative New Diagnostics Company Overview
Foundation for Innovative New Diagnostics Company Snapshot
Foundation for Innovative New Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
Foundation for Innovative New Diagnostics – Pipeline Analysis Overview
Foundation for Innovative New Diagnostics - Key Facts
Foundation for Innovative New Diagnostics - Major Products and Services
Foundation for Innovative New Diagnostics Pipeline Products by Development Stage
Foundation for Innovative New Diagnostics Pipeline Products Overview
2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis
2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis Product Overview
BART - Malaria
BART - Malaria Product Overview
High Throughput LAMP Kit - Malaria
High Throughput LAMP Kit - Malaria Product Overview
Infection Detection Test - P. falciparum
Infection Detection Test - P. falciparum Product Overview
LAM Antigen Detection Test
LAM Antigen Detection Test Product Overview
Lamp Assay - Buruli Ulcer
Lamp Assay - Buruli Ulcer Product Overview
MDR - XDRTB Color Test
MDR - XDRTB Color Test Product Overview
P. vivax Serology Test
P. vivax Serology Test Product Overview
Protein Antigen Capture Assay - Bureli Ulcer
Protein Antigen Capture Assay - Bureli Ulcer Product Overview
Rapid Diagnostic Test - Neoptrin/CXCL13
Rapid Diagnostic Test - Neoptrin/CXCL13 Product Overview
Single Format IgM Quantification Test
Single Format IgM Quantification Test Product Overview
Foundation for Innovative New Diagnostics - Key Competitors
Foundation for Innovative New Diagnostics - Key Employees
Foundation for Innovative New Diagnostics - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Foundation for Innovative New Diagnostics, Recent Developments
Mar 27, 2012: BD And FIND Extend Pricing Agreement To Reach HIV-Positive Patients In India
Jun 07, 2007: FIND Study Shows Successful Use Of LAMP Technology At Peripheral Levels Of The Health System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Foundation for Innovative New Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
Foundation for Innovative New Diagnostics Pipeline Products by Equipment Type
Foundation for Innovative New Diagnostics Pipeline Products by Indication
Foundation for Innovative New Diagnostics, Key Facts
Foundation for Innovative New Diagnostics, Major Products and Services
Foundation for Innovative New Diagnostics Number of Pipeline Products by Development Stage
Foundation for Innovative New Diagnostics Pipeline Products Summary by Development Stage
2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis - Product Status
2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis - Product Description
BART - Malaria - Product Status
BART - Malaria - Product Description
High Throughput LAMP Kit - Malaria - Product Status
High Throughput LAMP Kit - Malaria - Product Description
Infection Detection Test - P. falciparum - Product Status
Infection Detection Test - P. falciparum - Product Description
LAM Antigen Detection Test - Product Status
LAM Antigen Detection Test - Product Description
Lamp Assay - Buruli Ulcer - Product Status
Lamp Assay - Buruli Ulcer - Product Description
MDR - XDRTB Color Test - Product Status
MDR - XDRTB Color Test - Product Description
P. vivax Serology Test - Product Status
P. vivax Serology Test - Product Description
Protein Antigen Capture Assay - Bureli Ulcer - Product Status
Protein Antigen Capture Assay - Bureli Ulcer - Product Description
Rapid Diagnostic Test - Neoptrin/CXCL13 - Product Status
Rapid Diagnostic Test - Neoptrin/CXCL13 - Product Description
Single Format IgM Quantification Test - Product Status
Single Format IgM Quantification Test - Product Description
Foundation for Innovative New Diagnostics, Key Employees
Foundation for Innovative New Diagnostics, Other Locations
Glossary

LIST OF FIGURES

Foundation for Innovative New Diagnostics Pipeline Products by Equipment Type
Foundation for Innovative New Diagnostics Pipeline Products by Development Stage

COMPANIES MENTIONED

Ziemer Ophthalmic Systems AG
Inpeco SA
Diagene laboratories inc
Axon Lab AG
Skip to top


Ask Your Question

Foundation for Innovative New Diagnostics - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: